MDT

81.74

-1.59%↓

VEEV

209.29

-2.32%↓

98.9

-4.01%↓

CHE

569.14

-0.87%↓

HQY

76.28

-4.98%↓

MDT

81.74

-1.59%↓

VEEV

209.29

-2.32%↓

98.9

-4.01%↓

CHE

569.14

-0.87%↓

HQY

76.28

-4.98%↓

MDT

81.74

-1.59%↓

VEEV

209.29

-2.32%↓

98.9

-4.01%↓

CHE

569.14

-0.87%↓

HQY

76.28

-4.98%↓

MDT

81.74

-1.59%↓

VEEV

209.29

-2.32%↓

98.9

-4.01%↓

CHE

569.14

-0.87%↓

HQY

76.28

-4.98%↓

MDT

81.74

-1.59%↓

VEEV

209.29

-2.32%↓

98.9

-4.01%↓

CHE

569.14

-0.87%↓

HQY

76.28

-4.98%↓

Home・Elenco Azioni・Essa Pharma Inc

Essa Pharma Inc

Chiusa

1.44 2.86

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

1.41

Massimo

1.53

Metriche Chiave
By Trading Economics
Entrata	-2.2M -8.5M
EPS	-0.272
Dipendenti	35
EBITDA	-3.6M -9.9M

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	66M
Apertura precedente	-1.42
Chiusura precedente	1.44

Punteggio Tecnico

By Trading Central

Fiducia

Bearish Evidence

1.42 / 1.54 Supporto e resistenza

Essa Pharma Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

8 apr 2025, 22:42 UTC

I principali Market Mover

Peabody Energy Shares Climb on Trump Executive Orders Boosting Coal Industry

8 apr 2025, 22:35 UTC

Utili

I principali Market Mover

Cal-Maine Foods Shares Fall As Justice Dept Probes Egg Prices

8 apr 2025, 21:30 UTC

Utili

Cal-Maine Foods Cooperating With Justice Dept Probe Into Egg Price Increases -- Update

8 apr 2025, 21:21 UTC

Utili

Cal-Maine Foods Cooperating With Justice Dept Probe into Egg Price Increases

9 apr 2025, 00:00 UTC

Notizie principali

Trump's Tariffs Put Fed Chair Powell in a 'No-Win Situation' -- WSJ

8 apr 2025, 23:45 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

8 apr 2025, 23:45 UTC

Discorsi di Mercato

Nikkei May Fall Amid U.S. Tariff Uncertainty -- Market Talk

8 apr 2025, 23:43 UTC

Discorsi di Mercato

Lithium Oversupply Weighs on Price Outlook -- Market Talk

8 apr 2025, 23:43 UTC

Acquisizioni, Fusioni, Takeovers

Woolworths' Rivals Have Other Options to Source Ready Meals, ACCC Says

8 apr 2025, 23:42 UTC

Discorsi di Mercato

Gold Falls on Possible Unwinding of Long Positions to Raise Cash -- Market Talk

8 apr 2025, 23:42 UTC

Acquisizioni, Fusioni, Takeovers

Beak & Johnston Makes Ready Meals, Pastries for Wholesale, Retail

8 apr 2025, 23:41 UTC

Acquisizioni, Fusioni, Takeovers

Woolworths' Acquisition Unlikely to Have Substantial Anti-Competitive Effect, ACCC Says

8 apr 2025, 23:40 UTC

Acquisizioni, Fusioni, Takeovers

Australian Competition and Consumer Commission: Will Not Oppose Transaction

8 apr 2025, 23:39 UTC

Acquisizioni, Fusioni, Takeovers

Australian Competition Regulator to Allow Woolworths' Acquisition of Beak & Johnston

8 apr 2025, 23:21 UTC

Acquisizioni, Fusioni, Takeovers

U.S. Steel: $75 per Shr That the Ancora 'Plan' Proposes Is Really an Unrealistic, Distant Future Value Pipedream Rooted Firmly in Fiction >X

8 apr 2025, 23:21 UTC

Acquisizioni, Fusioni, Takeovers

U.S. Steel: Stockholders Should Be Very Skeptical of Ancora's 'Plan' or That Their Nominees Could or Would Vigorously Fight for the Nippon Steel Deal >X

8 apr 2025, 21:26 UTC

Notizie principali

When Coffee Mate Made a 'White Lotus' Piña Colada Creamer, It Had No Idea How the Season Would End -- WSJ

8 apr 2025, 21:26 UTC

Utili

Pfizer Stock's Fall to '97 Level Lifts Yield Near 8%. Dividend Looks Safe. -- Barrons.com

8 apr 2025, 21:18 UTC

Acquisizioni, Fusioni, Takeovers

Peabody Energy: Remains in Conversation With Anglo Amer to Better Understand Impacts of Event, Preserving All Rights and Protections Under Purchase Agreements >BTU

8 apr 2025, 21:18 UTC

Acquisizioni, Fusioni, Takeovers

Peabody Energy: Following Ignition Event Last Week at Anglo Amer's Moranbah North Mine, Reviewing Options Related to Acquisition of Steelmaking Coal Assets From Anglo Amer >BTU

8 apr 2025, 21:06 UTC

Notizie principali

Stocks Are in Turmoil, but Treasury Yields Are Stubbornly High -- Update

8 apr 2025, 20:50 UTC

Notizie principali

Harley-Davidson Seeks New CEO, Facing Sales Slump and Tariffs -- 3rd Update

8 apr 2025, 20:50 UTC

Discorsi di Mercato

Financial Services Roundup: Market Talk

8 apr 2025, 20:50 UTC

Discorsi di Mercato

Auto & Transport Roundup: Market Talk

8 apr 2025, 20:40 UTC

Utili

BYD Stock Soars. It's Catching Up to Tesla in Yet Another Way. -- Barrons.com

8 apr 2025, 20:28 UTC

Utili

Sandstorm Gold: Will Release 1Q Results on May 6 After Markets Close >SSL.T

8 apr 2025, 20:28 UTC

Utili

Sandstorm Gold: During Three Mos Ended March 31, Realized Record Preliminary Revenue of $50.1M (20,316 Attributable Gold Equivalent Ounces and $42.8M in Rev for the Comparable Period in 2024) >SSL.T

8 apr 2025, 20:28 UTC

Utili

Sandstorm Gold: Record Preliminary Total Sales, Royalties, Income From Other Interests of $54.1M for Three Mos Ended March 31 ($42.8M in Total Sales, Royalties, Income From Other Interests for Comparable Period in 2024) >SSL.T

8 apr 2025, 20:28 UTC

Utili

Sandstorm Gold: During Three Mos Ended March 31, Sold Approximately 18,500 Attributable Gold Equivalent Ounces >SSL.T

8 apr 2025, 20:14 UTC

Notizie principali

U.S. Stocks Retreat as Optimism Over Trade Talks Fades -- WSJ

Confronto tra pari

Modifica del prezzo

Essa Pharma Inc Previsione

Consenso sulla valutazione

By TipRanks

0 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 0 che hanno fornito valutazioni azionarie a Essa Pharma Inc - Dist negli ultimi 3 mesi.

Punteggio Tecnico

By Trading Central

1.42 / 1.54Supporto e resistenza

Recent bearish events outweigh bullish events.

All events are bullish.

All events are bearish.

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Essa Pharma Inc

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company's lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer. It has collaboration agreements with Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.